期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
琥珀酰明胶注射液降低肾脏摄取^(68)Ga-exendin-4的随机对照研究 被引量:3
1
作者 罗亚平 潘青青 +1 位作者 朱朝晖 李方 《标记免疫分析与临床》 CAS 2018年第9期1253-1258,共6页
目的以胰高血糖素样肽-1受体为靶点的^(68)Ga-exendin-4PET/CT是近年来新兴的诊断胰岛素瘤的新技术。由于^(68)Ga-exendin-4在肾脏异常浓聚,本研究旨在探明琥珀酰明胶注射液降低肾脏摄取^(68)Ga-exendin-4的有效性。方法本研究为随机对... 目的以胰高血糖素样肽-1受体为靶点的^(68)Ga-exendin-4PET/CT是近年来新兴的诊断胰岛素瘤的新技术。由于^(68)Ga-exendin-4在肾脏异常浓聚,本研究旨在探明琥珀酰明胶注射液降低肾脏摄取^(68)Ga-exendin-4的有效性。方法本研究为随机对照研究,研究纳入≥18岁且肾功能正常的拟行^(68)Ga-exendin-4 PET/CT的患者,随机分为实验组及对照组。实验组经静脉滴注500mL琥珀酰明胶注射液,对照组滴注500mL 5%葡萄糖氯化钠注射液,滴注完毕后即刻经静脉注射^(68)Ga-exendin-4示踪剂,之后行PET/CT检查,并测量肾脏、胰岛素瘤病灶和正常胰腺组织的SUV。结果研究共入组29例患者,实验组及对照组分别为14例,1例因对琥珀酰明胶注射液过敏退出本研究。实验组及对照组的年龄、性别、体重、体质指数、肾功能、^(68)Ga-exendin-4的注射剂量、显像间隔时间差异均无统计学意义。实验组肾脏的平均SUV和最高SUV均显著低于对照组(P <0. 0001),琥珀酰明胶注射液预滴注可将肾脏的放射性摄取降低59%。实验组和对照组的胰岛素瘤病灶的平均SUV、最高SUV差异无统计学意义,但实验组的正常胰腺组织平均SUV显著高于对照组(P<0.0001)。结论琥珀酰明胶注射液能够安全、有效的降低人体肾脏对^(68)Ga-exendin-4的摄取。 展开更多
关键词 胰高血糖素样肽-1受体 ^^68ga-exendin-4 肾脏 琥珀酰明胶
下载PDF
Decreased ^(68)Ga-NOTA-exendin-4 renal uptake in patients pretreated with Gelofusine infusion: a randomized controlled study 被引量:1
2
作者 Yaping Luo Qingqing Pan Fang Li 《Journal of Pancreatology》 2020年第3期161-166,共6页
Objective:Glucagon-like peptide-1 receptor imaging,using 68Ga-NOTA-exendin-4 is recently established for detecting insulinomas.Owing to the highly radioactive kidneys in 68Ga-NOTA-exendin-4 PET/CT,we aimed to determin... Objective:Glucagon-like peptide-1 receptor imaging,using 68Ga-NOTA-exendin-4 is recently established for detecting insulinomas.Owing to the highly radioactive kidneys in 68Ga-NOTA-exendin-4 PET/CT,we aimed to determine the effectiveness of Gelofusine in reducing renal uptake of 68Ga-NOTA-exendin-4.Methods:In our randomized controlled study,patients presenting for 68Ga-NOTA-exendin-4 PET/CT who were18 years and with normal renal function were enrolled,and then randomized into intervention group and control group.Patients in intervention group(group 1)underwent infusion of 500mL Gelofusine prior to PET/CT procedures:patients injected with 68Ga-NOTA-exendin-4(group 1a)immediately after 500mL Gelofusine infusion was completed;(group 1b)at the time point that 250 to 300mL Gelofusine infusion was completed;(group 1c)30minutes after completion of 500mL Gelofusine infusion.The control group(group 2)received 500mL 5%glucose saline instead.PET/CT was then performed,and SUVs of the kidneys and insulinomas were measured.Results:A total of 28 patients were recruited.There were 7 patients(14 kidneys)in each subgroup.The age,body weight,BMI,renal function,injected 68Ga-exendin-4 activity,and interval between injection of the tracer and PET/CT scan were not significantly different among the groups(P>.05).The average and maximum SUVs in the kidneys were significantly reduced in patients of intervention group compared with the control subjects(P<.0001),and the renal uptake could be decreased by 57%with Gelofusine pretreatment.No significant difference in the renal radioactivity was found among group 1a,1b,and 1c(P=.071).The uptake of insulinomas was not significantly different between the intervention and control groups.Conclusion:Renal uptake of 68Ga-exendin-4 can be effectively reduced by pretreatment with Gelofusine.Abbreviations:GLP-1R=Glucagon-like peptide-1 receptor;PRRT=peptide receptor radionuclide therapy;PET=positron emission tomography;SUV=standard uptake value. 展开更多
关键词 ^^(68)ga-NOTA-exendin-4 GELOFUSINE Glucagon-like peptide-1 receptor Kidney
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部